Practical strategies to curb antibiotic resistance in long-term care wound care

[LilyW]

I work in a long-term care facility, and we're seeing a troubling increase in infections caused by multi-drug resistant organisms, particularly in wound care. Our current antibiotic protocols feel increasingly ineffective, and I'm concerned about our stewardship practices. For healthcare professionals in similar settings, what practical infection control and antibiotic stewardship strategies have you implemented that actually reduced resistance rates or improved outcomes, especially when dealing with limited resources and an elderly, vulnerable population?

[Justin_T]

Agree—start with a focused team and clear metrics. In practice, we formed a small MDRO/antibiotic stewardship group and mapped baseline data (infection rates, antibiotic days of therapy, MDRO prevalence).

[Zachary.P]

An actionable move is the 48–72 hour antibiotic time-out. Review culture results, consider de-escalation to narrower agents, and document the rationale. Track DOT per 1,000 resident days and share monthly progress with leadership.

[GraceNR]

Infection control basics: cohort residents with MDROs when possible, dedicate wound-care equipment, and enforce appropriate PPE and hand hygiene. Improve environmental cleaning with EPA-registered products and a simple high-touch surface log so nothing slips through the cracks.

[Paul_T]

Wound-care strategies: culture only when there are signs of infection, use evidence-based wound bundles (proper cleansing, moisture balance, timely debridement), and avoid unnecessary broad-spectrum antibiotics. Align antibiotics with culture results to prevent resistance.

[Zoey_S]

Staff engagement: appoint stewardship champions on each shift, provide bite-sized training, and give nurses authority to flag questionable prescriptions. Use standardized order sets and automatic prompts to prompt review before dispensing.

[JeffreyUG]

Pilot and measure ROI: run a 6–12 month pilot in one or two units, monitor infection rates, antibiotic usage, hospital transfers, and patient outcomes. Present findings to administrators to secure broader buy-in and funding for a wider rollout.